KM analysis over one year demonstrated a higher UTI-free survival probability in the GLP-1 RA combination group (88.7%) compared to the BTX-A-only group (84.5%), with a statistically significant log-rank test (χ2 = 4.136, p = 0.0420) (Figure 2). The gene discussed is GLP1R; the disease is bacterial urinary tract infection.